Recent Developments Raise Difficult Questions about Balancing Patient Access to Medication with Efforts to Limit Prescription Drug Costs: The Debate Over Limits on Manufacturer Support for Patient Expenses Is Far from Settled

Bibliographische Detailangaben

Veröffentlicht in:	Journal of health care compliance 2018-01, Vol.20 (1), p.21
1. Verfasser:	Furlow, Andrew
Format:	Artikel
Sprache:	eng
Schlagworte:	Economic aspects Laws, regulations and rules Pharmaceutical industry Prescriptions (Drugs)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!